TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 8 | 1 | -20 | 53 | 45 | 81 | 28 |
| P | %wins | 100 | 100 | 0 | 100 | 100 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/31/08 21:17 | 10/30/08 | EXEL | Exelixis Inc | DE | Health | Biolab | Commercial Physical & Biologi | Scangos George A | CA | DO | P,CEO | P | 80 | 3.20 | 6 | 25 | 2 | 1,296 | D | -67 | -70 | -59 | -54 | -52 | -19 | -29 | 7 | 8 | 1 | -20 | 53 | 45 | 81 |
8/28/08 13:33 | 8/26/08 | ANDS | Anadys Pharmaceuticals Inc | Health | Drug | Pharmaceutical Preparations | Scangos George A | CA | D | P | 27 | 2.70 | 0 | 10 | 43 | 33 | D | ||||||||||||||||
9/5/07 20:55 | 8/31/07 | ANDS | Anadys Pharmaceuticals Inc | Health | Drug | Pharmaceutical Preparations | Scangos George A | CA | D | P | 48 | 2.17 | 0 | 22 | 999% | 23 | D | ||||||||||||||||
4/26/05 16:22 | 3/31/04 | ANDS | Anadys Pharmaceuticals Inc | Health | Drug | Pharmaceutical Preparations | Scangos George A | CA | D | P | 7 | 7.00 | 0 | 1 | New | 1 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |